世界の医薬品用原薬(API)市場...市場調査レポートについてご紹介

【英文タイトル】Global API Market Outlook 2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Analyst View
2. Research Methodology
3. APIs – An Introduction
4. Global API Industry
5. Drivers & Challenges
5.1 Drivers
5.1.1 Rise in Geriatric Population
5.1.2 Increasing Prevalence of Chronic Diseases
5.1.3 Patent Expiry Opening Market for Generic APIs
5.1.4 Asian Markets Offer Considerable Growth Potential
5.2 Challenges
5.2.1 Surging Prices Holding Back Branded Drug Market
5.2.2 Increasingly Challenging Regulatory Environment
5.2.3 Lengthy Product Approval Process
5.2.4 Lack of Transparency in Supply Chain
6. Market Segmentation
6.1 By Type of Manufacturing
6.1.1 Captive Market
6.1.2 Merchant Market
6.2 By Type of Drug
6.2.1 Generic Drug API
6.2.2 Branded Drug API
6.3 By Type of API
6.3.1 Chemical/Small Molecule API
6.3.2 Biotech API
6.4 By Key Geographical Markets
6.4.1 North America
6.4.2 Asia-Pacific
6.4.3 Europe
6.4.4 Rest of the World
6.5 By Therapeutic Segments
6.5.1 Cardiovascular Diseases
6.5.2 Diabetes
6.5.3 Central Nervous System Disorders
6.5.4 Oncology
6.5.5 Others
7. Trends and Developments
7.1 Nanocrystals of APIs to Improve Solubility
7.2 Technological Advancements Aiding API Production
8. Competitive Landscape
8.1 BASF SE
8.2 Kyowa Hakko Kirin
8.3 Teva Active Pharmaceuticals Ingredients
8.4 Lonza
8.5 Dr. Reddy’s Laboratories
8.6 Aurobindo Pharma Limited
8.7 Pfizer
8.8 Divis Laboratories Limited
8.9 Royal DSM
8.10 Boehringer Ingelheim GmbH

List of Figures:

Figure 4-1: Global – API Market (Billion US$), 2014-2020
Figure 5-1: Worldwide Population above 60 Years (Billion), 2014 & 2050
Figure 5-2: US – Population Suffering from Chronic Condition (Million), 2014 & 2020
Figure 6-1: Global – Share of Captive and Merchant Market in API Market (2014)
Figure 6-2: Global – API Captive Market (Billion US$), 2014-2020
Figure 6-3: Global – API Merchant Market (Billion US$), 2014-2020
Figure 6-4: Global – Share of Branded and Generic Market in API Market (2014)
Figure 6-5: Global – Generic API Market (Billion US$), 2014-2020
Figure 6-6: Global – Branded API Market (Billion US$), 2014-2020
Figure 6-7: Global – Share of Synthetic and Biotech APIs in API Market (2014)
Figure 6-8: Global – Chemical/Small Molecule API Market (Billion US$), 2014-2020
Figure 6-9: Global – Biotech API Market (Billion US$), 2014-2020
Figure 6-10: North America – API Market (Billion US$), 2014-2020
Figure 6-11: Asia-Pacific – API Market (US$ Billion), 2014-2020
Figure 6-12: Europe – API Market (Billion US$), 2014-2020
Figure 6-13: ROW – API Market (Billion US$), 2014-2020
Figure 6-14: Breakup of Global API Market by Therapeutic Segments (%), 2014
Figure 8-1: BASF SE – Break up of Revenue by Geographic Segment (%), 2014
Figure 8-2: Kyowa Hakko Kirin – Break up of Revenue by Geographic Segment (%), 2014
Figure 8-3: Teva Pharmaceutical Industries Limited – Break up of Revenue by Geographical Segment (%), 2014
Figure 8-4: Lonza – Break up of Revenue by Geographic Segment (%), 2014
Figure 8-5: Dr. Reddy’s Laboratories – Break up of Revenue by Geographic Segment (%), 2014
Figure 8-6: Aurobindo Pharma Limited – Break up of Revenue by Geographic Segment (%), 2014
Figure 8-7: Pfizer – Break up of Revenue by Geographic Segment (%), 2014
Figure 8-8: Divis Laboratories Limited – Break up of Revenue by Geographic Segment (%), 2014
Figure 8-9: Royal DSM – Break up of Revenue by Geographic Origin (%), 2014
Figure 8-10: Boehringer Ingelheim GmbH – Break up of Revenue by Geographic Segment (%), 2014

List of Tables:

Table 3-1: Classification of Bulk Drugs
Table 5-1: Blockbuster Drugs Going Off Patent (2014-2015)
Table 8-1: BASF SE – Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-2: Kyowa Hakko Kirin – Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-3: Teva Pharmaceutical Industries Limited – Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-4: Lonza – Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-5: Dr. Reddy’s Laboratories – Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-6: Aurobindo Pharma Limited – Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-7: Pfizer – Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-8: Divis Laboratories Limited – Revenues (Billion US$), 2013 & 2014
Table 8-9: Royal DSM – Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-10: Boehringer Ingelheim GmbH – Revenues by Business Segment (Billion US$), 2013 & 2014


【レポート販売概要】

■ タイトル:世界の医薬品用原薬(API)市場
■ 英文:Global API Market Outlook 2020
■ 発行日:2015年9月
■ 調査会社:RNCOS
■ 商品コード:RNCOS50907
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。